Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2020 Jul 13;27(Suppl 3):798–800. doi: 10.1111/odi.13496

Altered taste in patients with COVID‐19: The potential role of salivary glands

Marlus da Silva Pedrosa 1,✉, Carla Renata Sipert 2, Fernando Neves Nogueira 1
PMCID: PMC7323242  PMID: 32564416

Dear Editor,

The novel coronavirus disease (COVID‐19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) constitutes a public health emergency of international concern. Taste and smell disorders have been reported along with various other clinical problems. In some studies (Fitzgerald, 2020; Machado & Gutierrez, 2020; Parma et al., 2020; Yan, Faraji, Prajapati, Boone, & DeConde, 2020), smell and taste disturbances have been reported in COVID‐19‐positive subjects, suggesting that chemosensory dysfunction should be considered when screening for this disease. In this manuscript, the possible influence of salivary gland dysfunction and hyposalivation in the chemosensory disorders observed in COVID‐19 patients is briefly discussed.

SARS‐CoV‐2 uses angiotensin‐converting enzyme‐2 (ACE2) as an important receptor for entry and transmembrane serine protease 2 (TMPRSS2) for priming (Hoffmann et al., 2020). In addition, the spike viral protein of SARS‐CoV‐2 appears to be depended on sialic acid‐rich proteins and gangliosides GM1 for coupling (Fantini, Di Scala, Chahinian, & Yahi, 2020). Gangliosides GM1 have an important role in many cellular processes facilitating pathogen entry (Schnaar, 2019). Saliva, a biological fluid produced by the major and minor salivary glands, contains water, ions, and several protein groups, including mucins, which have sialic acid in its composition (Shogren, Gerken, & Jentoft, 1989). The salivary glands were shown to present ACE2 (Liu et al., 2011; Xu, Li, Gan, Du, & Yao, 2020), TMPRSS2 (Vaarala, Porvari, Kellokumpu, Kyllönen, & Vihko, 2001), and gangliosides GM1 (Nowroozi, Kawata, Liu, Rice, & Zernik, 2001). Taken together, these demonstrate the possibility of salivary gland infection by SARS‐CoV‐2 (Chen, Zhao, et al., 2020).

Hyposalivation was hypothesized to expose patients to a higher risk of contracting COVID‐19, as the reduction in saliva secretion may impair the secretion of antimicrobial proteins and peptides that illustrate antiviral activity, particularly against coronaviruses (Farshidfar & Hamedani, 2020). Hyposalivation, a condition that has been mostly reported as an adverse effect of drugs, radiotherapy of head and neck tumors, and Sjögren's syndrome (Villa, Connell, & Abati, 2015), can also be caused by infectious and inflammatory processes. Thus, salivary gland infection driven by SARS‐CoV‐2 might also affect saliva secretion. Hyposalivation and disturbances in salivary biomarkers may cause xerostomia (Farsi, 2007; Romero, Ibuki, & Nogueira, 2012), which has been associated with oral sensorial complaints (Mortazavi, Baharvand, Movahhedian, Mohammadi, & Khodadoustan, 2014). Moreover, oral neuropathy or neurological transduction interruption induced by salivary compositional alterations is responsible for oral sensory complaints and loss of taste function (Henkin, 1999; Hershkovich & Nagler, 2004). Psychological factors may also affect salivary flow rate and composition (M Bergdahl & Bergdahl, 2000; Gholami, Sabzvari, Razzaghi, & Salah, 2017), and thus, the psychological effects of the COVID‐19 (Dong & Bouey, 2020; Duan & Zhu, 2020) on salivary gland secretion and taste disturbances (Maud Bergdahl & Bergdahl, 2002) could not be ignored.

Coronaviruses, including SARS‐CoV‐2, have neuroinvasive capacities since they can spread from the respiratory tract to the central nervous system (Desforges, Le Coupanec, Stodola, Meessen‐Pinard, & Talbot, 2014; Li, Bai, & Hashikawa, 2020). In addition, there are reports of cranial nerve involvement and neurologic manifestations of SARS‐CoV‐2 (Troyer, Kohn, & Hong, 2020; Vonck et al., 2020). The reported taste disturbances in COVID‐19‐positive subjects have only been subjective in nature, and it remains unknown if patients have actual disturbances in their sense of taste or whether they are experiencing a disturbance in flavor, which is a combination of olfactory, gustatory, and trigeminal inputs (Bromley, 2000; Fitzgerald, 2020; Parma et al., 2020; Yan et al., 2020). SARS‐CoV‐2 is capable of directly infecting olfactory neuroepithelium, which is the prevailing theory for taste dysfunction (Chen, Shen, et al., 2020; Fodoulian et al., 2020). Thus, taste alterations resulting from the direct effect of SARS‐CoV‐2 infection on sensory neurons or other components of the peripheral gustatory system should also be considered.

Therefore, salivary gland infection and consequent disturbances in salivary flow rate and composition might be among the possible causes of taste alterations caused by SARS‐CoV‐2. Since the pathophysiology of COVID‐19 remains not fully elucidated, studies are necessary to understand the real role of salivary glands and saliva in the taste alterations observed in COVID‐19 patients.

CONFLICT OF INTEREST

The author declare no potential conflict of interest with respect to the authorship and/or publication of this article.

AUTHOR CONTRIBUTION

Marlus da Silva Pedrosa: Conceptualization; Data curation; Formal analysis; Methodology; Supervision; Validation; Visualization; Writing‐original draft; Writing‐review & editing. Carla Renata Sipert: Conceptualization; Supervision; Writing‐review & editing. Fernando Neves Nogueira: Conceptualization; Supervision; Writing‐original draft; Writing‐review & editing.

Funding information

This study was supported by the São Paulo Research Foundation (No. 2019/14556‐7) and scholarship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—CAPES.

REFERENCES

  1. Bergdahl, M. , & Bergdahl, J. (2000). Low unstimulated salivary flow and subjective oral dryness: Association with medication, anxiety, depression, and stress. Journal of Dental Research, 79(9), 1652–1658. 10.1177/00220345000790090301 [DOI] [PubMed] [Google Scholar]
  2. Bergdahl, M. , & Bergdahl, J. (2002). Perceived taste disturbance in adults: Prevalence and association with oral and psychological factors and medication. Clinical Oral Investigations, 6(3), 145–149. 10.1007/s00784-002-0169-0 [DOI] [PubMed] [Google Scholar]
  3. Bromley, S. M. (2000). Smell and taste disorders: A primary care approach. American Family Physician, 61(2), 427–436. [PubMed] [Google Scholar]
  4. Chen, L. , Zhao, J. , Peng, J. , Li, X. , Deng, X. , Geng, Z. , … Wang, S. (2020). Detection of 2019‐nCoV in Saliva and Characterization of Oral Symptoms in COVID‐19 Patients. SSRN Electronic Journal. 10.2139/ssrn.3557140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen, M. , Shen, W. , Rowan, N. , Kulaga, H. , Hillel, A. , Ramanathan, M. , & Lane, A. P. (2020). Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS‐CoV‐2 entry and replication. bioRxiv. 10.1101/2020.05.08.084996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Desforges, M. , Le Coupanec, A. , Stodola, J. K. , Meessen‐Pinard, M. , & Talbot, P. J. (2014). Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Research, 194, 145–158. 10.1016/j.virusres.2014.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dong, L. , & Bouey, J. (2020). Public mental health crisis during COVID‐19 pandemic, China. Emerging Infectious Diseases, 26(7), 10.3201. 10.3201/eid2607.200407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duan, L. , & Zhu, G. (2020). Psychological interventions for people affected by the COVID‐19 epidemic. The Lancet Psychiatry, 7(4), 300–302. 10.1016/S2215-0366(20)30073-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fantini, J. , Di Scala, C. , Chahinian, H. , & Yahi, N. (2020). Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS‐CoV‐2 infection. International Journal of Antimicrobial agents, 105960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Farshidfar, N. , & Hamedani, S. (2020). Hyposalivation as a potential risk for SARS‐CoV‐2 infection: Inhibitory role of saliva. Oral Diseases. 10.1111/odi.13375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Farsi, N. M. (2007). Signs of oral dryness in relation to salivary flow rate, pH, buffering capacity and dry mouth complaints. BMC Oral Health, 7(1), 15. 10.1186/1472-6831-7-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fitzgerald, S. (2020). Investigators ramp up research on loss of smell as early symptom of COVID‐19. Neurology Today, 20(9), 12–13. 10.1097/01.NT.0000666964.89379.18 [DOI] [Google Scholar]
  13. Fodoulian, L. , Tuberosa, J. , Rossier, D. , Landis, B. , Carleton, A. , & Rodriguez, I. (2020). SARS‐CoV‐2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. bioRxiv. 10.1101/2020.03.31.013268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gholami, N. , Sabzvari, B. H. , Razzaghi, A. , & Salah, S. (2017). Effect of stress, anxiety and depression on unstimulated salivary flow rate and xerostomia. Journal of Dental Research, Dental Clinics, Dental Prospects, 11(4), 247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Henkin, R. I. , Martin, B. M. , & Agarwal, R. P. (1999). Decreased parotid saliva gustin/carbonic anhydrase VI secretion: An enzyme disorder manifested by gustatory and olfactory dysfunction. The American Journal of the Medical Sciences, 318(6), 380–391. 10.1097/00000441-199912000-00005 [DOI] [PubMed] [Google Scholar]
  16. Hershkovich, O. , & Nagler, R. M. (2004). Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Archives of Oral Biology, 49(7), 515–522. 10.1016/j.archoralbio.2004.01.012 [DOI] [PubMed] [Google Scholar]
  17. Hoffmann, M. , Kleine‐Weber, H. , Schroeder, S. , Krüger, N. , Herrler, T. , Erichsen, S. , … Pöhlmann, S. (2020). SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. 10.1016/j.cell.2020.02.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Li, Y.‐C. , Bai, W.‐Z. , & Hashikawa, T. (2020). The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. Journal of Medical Virology, 92(6), 552–555. 10.1002/jmv.25728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liu, L. , Wei, Q. , Alvarez, X. , Wang, H. , Du, Y. , Zhu, H. , … Chen, Z. (2011). Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. Journal of Virology, 85(8), 4025–4030. 10.1128/JVI.02292-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Machado, C. , & Gutierrez, J. V. (2020). Anosmia and ageusia as initial or unique symptoms after sars‐cov‐2 virus infection. Preprints 2020, 2020040272. 10.20944/preprints202004.0272.v1 [DOI] [Google Scholar]
  21. Mortazavi, H. , Baharvand, M. , Movahhedian, A. , Mohammadi, M. , & Khodadoustan, A. (2014). Xerostomia due to systemic disease: A review of 20 conditions and mechanisms. Annals of Medical and Health Sciences Research, 4(4), 503–510. 10.4103/2141-9248.139284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nowroozi, N. , Kawata, T. , Liu, P. , Rice, D. , & Zernik, J. H. (2001). High β‐galactosidase and ganglioside GM1 levels in the human parotid gland. Archives of Otolaryngology‐Head & Neck Surgery, 127(11), 1381–1384. 10.1001/archotol.127.11.1381 [DOI] [PubMed] [Google Scholar]
  23. Parma, V. , Ohla, K. , Veldhuizen, M. G. , Niv, M. Y. , Kelly, C. E. , Bakke, A. J. , & Dibattista, M. (2020). More than just smell‐COVID‐19 is associated with severe impairment of smell, taste, and chemesthesis. medRxiv. 10.1101/2020.05.04.20090902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Romero, A. C. , Ibuki, F. K. , & Nogueira, F. N. (2012). Sialic acid reduction in the saliva of streptozotocin induced diabetic rats. Archives of Oral Biology, 57(9), 1189–1193. 10.1016/j.archoralbio.2012.02.016 [DOI] [PubMed] [Google Scholar]
  25. Schnaar, R. L. (2019). Chapter Three ‐ The Biology of Gangliosides. In Baker D. C. (Ed.), Advances in Carbohydrate Chemistry and Biochemistry, Vol. 76 (pp. 113–148). Academic Press. [DOI] [PubMed] [Google Scholar]
  26. Shogren, R. , Gerken, T. A. , & Jentoft, N. (1989). Role of glycosylation on the conformation and chain dimensions of O‐linked glycoproteins: Light‐scattering studies of ovine submaxillary mucin. Biochemistry, 28(13), 5525–5536. 10.1021/bi00439a029 [DOI] [PubMed] [Google Scholar]
  27. Troyer, E. A. , Kohn, J. N. , & Hong, S. (2020). Are we facing a crashing wave of neuropsychiatric sequelae of COVID‐19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behavior, and Immunity, 87, 34–39. 10.1016/j.bbi.2020.04.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vaarala, M. H. , Porvari, K. S. , Kellokumpu, S. , Kyllönen, A. P. , & Vihko, P. T. (2001). Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. The Journal of Pathology, 193(1), 134–140. [DOI] [PubMed] [Google Scholar]
  29. Villa, A. , Connell, C. L. , & Abati, S. (2015). Diagnosis and management of xerostomia and hyposalivation. Therapeutics and Clinical Risk Management, 11, 45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vonck, K. , Garrez, I. , De Herdt, V. , Hemelsoet, D. , Laureys, G. , Raedt, R. , & Boon, P. (2020). Neurological manifestations and neuro‐invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2. European Journal of Neurology. 10.1111/ene.14329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Xu, J. , Li, Y. , Gan, F. , Du, Y. , & Yao, Y. (2020). Salivary Glands: Potential Reservoirs for COVID‐19 Asymptomatic Infection. Journal of Dental research, 0022034520918518. 10.1177/0022034520918518 [DOI] [PubMed] [Google Scholar]
  32. Yan, C. H. , Faraji, F. , Prajapati, D. P. , Boone, C. E. , & DeConde, A. S. (2020). Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms. International Forum of Allergy & Rhinology. 10.1002/alr.22579 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Oral Diseases are provided here courtesy of Wiley

RESOURCES